{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:53:36Z","timestamp":1793120016244,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014041","name":"ADNI","doi-asserted-by":"crossref","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100014041","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AstraZeneca AB"},{"name":"Bayer Schering Pharma AG"},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eisai Global Clinical Development"},{"DOI":"10.13039\/501100003037","name":"Elan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005061","name":"Innogenetics","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005061","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Eli Lilly and Co"},{"name":"Medpace Inc"},{"DOI":"10.13039\/100004334","name":"Merck & Co, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis AG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Pfizer Inc"},{"DOI":"10.13039\/100007013","name":"F. Hoffman-La Roche","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007110","name":"Schering-Plough","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007110","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Synarc Inc"},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.neurobiolaging.2014.07.036","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T23:09:42Z","timestamp":1406848182000},"page":"273-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment"],"prefix":"10.1016","volume":"36","author":[{"given":"Rachel L.","family":"Nosheny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6270-5490","authenticated-orcid":false,"given":"Philip S.","family":"Insel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7159-2216","authenticated-orcid":false,"given":"Diana","family":"Truran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Schuff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-622X","authenticated-orcid":false,"suffix":"Jr.","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Aisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7650-1210","authenticated-orcid":false,"given":"Leslie M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Q.","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib2","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/ana.22333","article-title":"Amyloid-beta associated cortical thinning in clinically normal elderly","volume":"69","author":"Becker","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archneur.65.8.1053","article-title":"Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan","volume":"65","author":"Brickman","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib4","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0197-4580(02)00130-6","article-title":"Comparison of methods for measuring longitudinal brain change in cognitive impairment and dementia","volume":"24","author":"Cardenas","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib5","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/archneurol.2010.284","article-title":"Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative","volume":"67","author":"Carmichael","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1148\/radiology.197.2.7480705","article-title":"H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia","volume":"197","author":"Constans","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib8","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1523\/JNEUROSCI.14-08-04748.1994","article-title":"Sex differences in aging of the human frontal and temporal lobes","volume":"14","author":"Cowell","year":"1994","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib9","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.neuroimage.2009.12.116","article-title":"Effects of ApoE-epsilon4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons","volume":"53","author":"Crivello","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib10","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1212\/WNL.0b013e3182166e96","article-title":"Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults","volume":"76","author":"Dickerson","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.neurobiolaging.2005.03.021","article-title":"Age effects on atrophy rates of entorhinal cortex and hippocampus","volume":"27","author":"Du","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/01.WNL.0000044400.11317.EC","article-title":"Atrophy rates of entorhinal cortex in AD and normal aging","volume":"60","author":"Du","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.21559","article-title":"Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly","volume":"65","author":"Fagan","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib14","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.neurobiolaging.2011.03.017","article-title":"Maximal brain size remains an important predictor of cognition in old age, independent of current brain pathology","volume":"33","author":"Farias","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/cercor\/bhg087","article-title":"Automatically parcellating the human cerebral cortex","volume":"14","author":"Fischl","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib17","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/cercor\/bhp279","article-title":"Brain atrophy in healthy aging is related to CSF levels of Abeta1-42","volume":"20","author":"Fjell","year":"2010","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib18","doi-asserted-by":"crossref","first-page":"15223","DOI":"10.1523\/JNEUROSCI.3252-09.2009","article-title":"One-year brain atrophy evident in healthy aging","volume":"29","author":"Fjell","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archneur.61.1.59","article-title":"Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials","volume":"61","author":"Grundman","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib21","doi-asserted-by":"crossref","first-page":"e42325","DOI":"10.1371\/journal.pone.0042325","article-title":"Rates of decline in Alzheimer disease decrease with age","volume":"7","author":"Holland","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib22","doi-asserted-by":"crossref","first-page":"e47739","DOI":"10.1371\/journal.pone.0047739","article-title":"Enrichment and stratification for predementia Alzheimer disease clinical trials","volume":"7","author":"Holland","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib23","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/WNL.0b013e31820e7b74","article-title":"Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease","volume":"76","author":"Honea","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J.\u00a0Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib27","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","article-title":"11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment","volume":"131","author":"Jack","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib28","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1212\/WNL.49.3.786","article-title":"Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease","volume":"49","author":"Jack","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.21296","article-title":"Neuropathological basis of magnetic resonance images in aging and dementia","volume":"63","author":"Jagust","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib30","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.jalz.2012.10.007","article-title":"Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib31","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2967\/jnumed.111.090340","article-title":"Performance characteristics of amyloid PET with florbetapir F 18 in patients with Alzheimer's disease and cognitively normal subjects","volume":"53","author":"Joshi","year":"2012","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib32","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1073\/pnas.83.11.4044","article-title":"Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease","volume":"83","author":"Kosik","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib33","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.neuroimage.2011.07.098","article-title":"Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant","volume":"59","author":"Mormino","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib34","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awn320","article-title":"Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects","volume":"132","author":"Mormino","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib35","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.neuroimage.2008.10.043","article-title":"Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls","volume":"45","author":"Morra","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib36","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/archneurol.2009.269","article-title":"Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease","volume":"66","author":"Morris","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.58.3.397","article-title":"Mild cognitive impairment represents early-stage Alzheimer disease","volume":"58","author":"Morris","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib39","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib40","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib41","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ana.22315","article-title":"Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Abeta1-42","volume":"68","author":"Schott","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib42","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neurobiolaging.2010.07.012","article-title":"Nonlinear time course of brain volume loss in cognitively normal and impaired elders","volume":"33","author":"Schuff","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib43","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/mrm.1910080210","article-title":"Quantitative NMR measurements of hippocampal atrophy in Alzheimer's disease","volume":"8","author":"Seab","year":"1988","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib45","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/cercor\/bhl066","article-title":"Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age","volume":"17","author":"Sowell","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib46","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archneurol.2009.272","article-title":"Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition","volume":"66","author":"Storandt","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib47","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.neurobiolaging.2010.04.030","article-title":"Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study","volume":"31","author":"Tosun","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jalz.2010.08.230","article-title":"Transforming cerebrospinal fluid Abeta42 measures into calculated Pittsburgh Compound B units of brain Abeta amyloid","volume":"7","author":"Weigand","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2014.07.036_bib49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archneurol.2011.3029","article-title":"Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging","volume":"69","author":"Whitwell","year":"2012","journal-title":"Arch. Neurol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014005053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458014005053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:23:13Z","timestamp":1759317793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458014005053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0197458014005053"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.036","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}